Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

RSS icon

Death after TAVR: Heart failure, sudden cardiac arrest stand out as 2 leading causes

A majority of patient deaths within two years of TAVR can be linked to cardiovascular complications, according to new research published in JACC: Cardiovascular Interventions. Can follow-up care be improved to combat this trend? 

Newsweek ranked the 50 best heart hospitals in the world

Cardiologists to celebrate World Heart Day with CCTA webinar

The free webinar, scheduled for Sept. 29, will examine the benefits of using CCTA and FFR-CT to manage chest pain patients. 

Thumbnail

AFib recurrence during the 90-day blanking period after ablation—nothing serious or a sign of trouble?

Asking patients to use smartphone-powered ECG devices following catheter ablation procedures could be incredibly beneficial, according to new findings published in JACC: Clinical Electrophysiology. 

Video of ASNC President Mouaz Al-Mallah, MD, explaining some long-COVID cardiac symptoms might be due to coronary microvascular dysfunction. He was part of a recent study that used PET top assess myocardial perfusion that found there is impaired microvascular flow in long-COVID patients.

PET imaging helps assess coronary microvascular dysfunction in long COVID patients

Researchers noted that patients appeared to have myocarditis at first, but a closer examination revealed it was something else entirely. 

Thumbnail

Bivalirudin linked to key benefit over heparin for NSTEMI patients undergoing PCI

The two anticoagulants are associated with similar mortality rates. However, a new meta-analysis in Circulation may have cardiologists favoring bivalirudin over heparin. 

Video of Prof. Dr. Ralph Stephan von Bardeleben explaining the latest details from key tricuspid valve trials.

What new tricuspid valve data tell us about the future of patient care

What are the latest updates on treating tricuspid regurgitation? We spoke with a leading researcher at ESC Congress 2023 to find out. 

Vivek Reddy, MD, director of arrhythmia service and processor of medicine in cardiac electrophysiology, Mt. Sinai, New York, expolains the key takeaways from the ADVENT trial of pulsed field ablation at ESC 2023.

Pulsed field ablation shows potential to replace thermal ablation

Vivek Reddy, MD, explained that pulsed field ablation is associated with many benefits compared to the current standard of care in electrophysiology. 

Thumbnail

EP studies during TAVR are safe and effective, new pilot study confirms

New research in JACC: Cardiovascular Interventions explored the potential of performing EP studies before and after valve deployment. TAVR operators handled all catheter manipulations, and EP specialists were on hand to capture the necessary measurements. 

Displaying 433 - 440 of 1689
Design by Adaptive Theme